FGF21 and metabolic dysfunction-associated steatohepatitis: Since the regression equation did not demonstrate better effect in diagnosing NASH than single biomarker did, we decided to use another form of biomarker combination, a 5-step approach measuring CK-18-M30 successively followed by FGF21, IL-1Ra, PEDF and OPG.